SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-24-031738
Filing Date
2024-03-15
Accepted
2024-03-14 18:44:47
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B3 evoke-_424b3_3.14.24.htm 424B3 2256523
2 GRAPHIC img71962864_0.jpg GRAPHIC 7479
3 GRAPHIC img71962864_1.jpg GRAPHIC 24883
4 GRAPHIC img71962864_2.jpg GRAPHIC 194336
  Complete submission text file 0000950170-24-031738.txt   2570020
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-275443 | Film No.: 24751789
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)